FIELD: medicine, oncology, pharmacy. SUBSTANCE: composition has, wt.-%: substituted benzimidazolium triiodide, 10-20; and polyvinylpyrrolidone, 80-90. New composition shows low toxicity, absence of mutagenic, teratogenic and immunotoxic effects. New composition inhibits tumor growth. EFFECT: enhanced effectiveness of composition. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING AN ANTIBACTERIAL AND ANTITUMOR DRUG | 1998 |
|
RU2129870C1 |
STABILIZED WATER-SOLUBLE COMPOSITION OF 1,2,3-TRIALKYLBENZ- -IMIDAZOLIUM TRIIODIDE | 1996 |
|
RU2150274C1 |
1,2,3-SUBSTITUTED BENZIMIDAZOLIUM DIIODOBROMIDES AND THEIR WATER-SOLUBLE COMPOSITION | 1998 |
|
RU2135476C1 |
QUATERNARY AMMONIUM BASE TRIIODIDES AND THEIR WATER-SOLUBLE COMPOSITION | 1998 |
|
RU2154053C2 |
1,2,3-SUBSTITUTED BENZIMIDAZOLIUM DIIODIDE CHLORIDES AND THEIR WATER-SOLUBLE COMPOSITION | 1999 |
|
RU2148578C1 |
ANTIMICROBIAL MEDICAL PREPARATION | 1992 |
|
RU2033164C1 |
1,2,3-TRISUBSTITUTED BENZIMIDAZOLIUM TRIIODIDES AND METHODS OF THEIR SYNTHESIS | 2000 |
|
RU2198880C2 |
IODINE-CONTAINING BIOLOGICALLY-ACTIVE COMPOSITION | 1999 |
|
RU2160090C2 |
BIOLOGICALLY ACTIVE COMPOSITION | 2017 |
|
RU2663931C1 |
1,3-DIETHYLBENZIMIDAZOLIUM SALTS - AGENTS FOR TREATING ONCOLOGICAL DISEASES AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2452485C1 |
Authors
Dates
1997-10-27—Published
1995-12-25—Filed